Bausch Health Companies Inc. (BHC) stock rises on Q1 2026 Earnings

Bausch Health Companies Inc. (BHC) reported first-quarter 2026 results.

Total revenue: $1.82 billion, down 19.6% year-over-year.

Gross profit: $1.28 billion, down 17.6% year-over-year.

Operating result: operating loss of $683.3 million, a decline of 347.6% year-over-year.

Net income attributable to common shareholders: net loss of $1.02 billion, a change of +1,664.7% year-over-year.

Diluted loss per share: -$3.82, a change of +2,287.5% year-over-year.

Cash flow and balance-sheet highlights:

Cash from operating activities: $230 million, up 9.0% year-over-year.

Capital expenditures (purchases of property, plant and equipment): $109 million (cash outflow), down 5.2% year-over-year.

Cash and cash equivalents: $1.31 billion, up 15.7% year-over-year.

Cost of sales: $530.8 million, down 24.3% year-over-year.

Total liabilities: $25.58 billion, down 4.1% year-over-year.

BHC shares were up 3.37% since market close.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Bausch Health Companies Inc. Insider Trading Activity

Bausch Health Companies Inc. insiders have traded $BHC stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BHC stock by insiders over the last 6 months:

& CO. INC. PAULSON purchased 2,500,000 shares for an estimated $15,625,000
SEANA CARSON (EVP, General Counsel) has made 0 purchases and 3 sales selling 19,664 shares for an estimated $115,039.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

Bausch Health Companies Inc. Hedge Fund Activity

We have seen 132 institutional investors add shares of Bausch Health Companies Inc. stock to their portfolio, and 77 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NOMURA HOLDINGS INC removed 7,008,552 shares (-44.6%) from their portfolio in Q4 2025, for an estimated $48,709,436
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 4,547,881 shares (-35.0%) from their portfolio in Q4 2025, for an estimated $31,607,772
UBS GROUP AG removed 4,540,973 shares (-88.2%) from their portfolio in Q4 2025, for an estimated $31,559,762
NORGES BANK added 3,664,972 shares (+20923.6%) to their portfolio in Q4 2025, for an estimated $25,471,555
MUFG SECURITIES EMEA PLC removed 3,400,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $23,630,000
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,518,064 shares (+1224.8%) to their portfolio in Q4 2025, for an estimated $17,500,544
PAULSON & CO. INC. added 2,500,000 shares (+3.5%) to their portfolio in Q4 2025, for an estimated $17,375,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

Bausch Health Companies Inc. Price Targets

Multiple analysts have issued price targets for $BHC recently. We have seen 3 analysts offer price targets for $BHC in the last 6 months, with a median target of $8.0.

Here are some recent targets:

Douglas Miehm from RBC Capital set a target price of $9.0 on 04/27/2026
Glen Santangelo from Barclays set a target price of $7.0 on 02/25/2026
Les Sulewski from Truist Securities set a target price of $8.0 on 01/07/2026